ReviewCurrent neurology and neuroscience reports2014
Imaging frontotemporal lobar degeneration.
Review in Current neurology and neuroscience reports, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- Musicality is Preserved in Neurodegeneration.The Yale journal of biology and medicine · 2026Review
- Disease specific and nonspecific metabolic brain networks in behavioral variant of frontotemporal dementia.Human brain mapping · 2023Article
- Clinical and neuroimaging characteristics of primary progressive aphasia.Handbook of clinical neurology · 2022Review
- Multiparametric magnetic resonance imaging and positron emission tomography findings in neurodegenerative diseases: Current status and future directions.The neuroradiology journal · 2021Review
- Clinical features of behavioral symptoms in patients with semantic dementia: Does semantic dementia cause autistic traits?PloS one · 2021Article
- Normative brain volume reports may improve differential diagnosis of dementing neurodegenerative diseases in clinical practice.European radiology · 2020Article
- Precision Medicine for Frontotemporal Dementia.Frontiers in psychiatry · 2019Review
- Imaging and fluid biomarkers in frontotemporal dementia.Nature reviews. Neurology · 2017Review
- Focal temporal pole atrophy and network degeneration in semantic variant primary progressive aphasia.Brain : a journal of neurology · 2017Article
- Quantification of the Relative Contributions of Loss-of-function and Gain-of-function Mechanisms in TAR DNA-binding Protein 43 (TDP-43) Proteinopathies.The Journal of biological chemistry · 2016Article
- Parkinsonism, movement disorders and genetics in frontotemporal dementia.Nature reviews. Neurology · 2016Review
- Imaging pathological tau in atypical parkinsonian disorders.Current opinion in neurology · 2015Review
- Amyloid and FDG-PET study of logopenic primary progressive aphasia: evidence for the existence of two subtypes.Journal of neurology · 2015Article
- [MRI in dementia-type diseases].Der Radiologe · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The term frontotemporal lobar degeneration (FTLD) refers to a group of neurodegenerative disorders that target the frontal and temporal lobes. It accounts for approximately 10 % of pathologically confirmed dementias but has been demonstrated to be as prevalent as Alzheimer's disease in patients below the age of 65. The 3 major clinical syndromes associated with FTLD include behavioral variant frontotemporal dementia, semantic and nonfluent variants of primary progressive aphasia. The more recently introduced term logopenic variant appears to represent an atypical form of Alzheimer's disease in the majority of cases. The neuropathology underlying these clinical syndromes is very heterogeneous and does not correlate well with the clinical phenotype. This causes great difficulties in early and reliable diagnosis and treatment of FTLD. However, significant advances have been made in recent years via the application of magnetic resonance imaging and positron emission tomography imaging methods as biomarkers. The current review aims to provide a synopsis on the value of magnetic resonance imaging-based and molecular imaging procedures in FTLD.
Indexed as
Identifiers
25171901What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.